HL
Hopen Life Science Ventures
Venture CapitalActiveHopen Life Science Ventures is a venture capital firm, investing in the life science and healthcare sectors.
11
Investments
1
Exits
—
AUM
9.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Hopen Life Science Ventures.
Investment Thesis & Strategy
Hopen Life Science Ventures invests in various stages of life science and healthcare companies. They focus on companies within the life science and healthcare sectors.
Investment Activity
Deals per year over the last 5 years
1
20200
20211
20221
20232
2024Portfolio Companies
Selected investments from their portfolio of 11 companies
A
Aegle Therapeutics
Biotech · Growth, 2024
A
Aegle Therapeutics
Biotech · Growth, 2024
A
Aegle Therapeutics
Biotech · Growth, 2023
A
Aegle Therapeutics
Biotech · Series B, 2022
A
Aegle Therapeutics
Biotech · Series A, 2020
Frequently Asked Questions
Hopen Life Science Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Michigan Accelerator Fund I
Grand Rapids, United States · 8 deals
Bridge Street Capital Partners
Grand Rapids, United States · 3 deals
Momentum
Grand Rapids, United States · 2 deals
K Group
Grand Rapids, United States · 1 deals
Bessemer Venture Partners
Redwood City, United States · 971 deals
Threshold
Menlo Park, United States · 841 deals